Monkeypox trial to begin in DR Congo
Lancet Infect Dis
.
2022 Oct;22(10):1425.
doi: 10.1016/S1473-3099(22)00604-1.
Author
Esther Nakkazi
PMID:
36152657
PMCID:
PMC9533941
DOI:
10.1016/S1473-3099(22)00604-1
No abstract available
Publication types
News
MeSH terms
Clinical Trials as Topic
Democratic Republic of the Congo / epidemiology
Humans
Mpox (monkeypox)* / drug therapy
Mpox (monkeypox)* / epidemiology
Mpox (monkeypox)* / prevention & control